Endogenous filamentous fungal endophthalmitis - single-centre survey in patients with acute leukaemia or postallogeneic stem cell transplantation and review of the literature

Mycoses

Volumn 54, Issue 6, 2011, Pages

  Vergoulidou, Maria ^a   Krause, Lothar ^a   Foerster, Michael H ^a   Thiel, Eckhard ^a   Schwartz, Stefan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute leukaemia; Aspergillus; Endogenous endophthalmitis; Filamentous fungi; Haematopoietic stem cell transplantation; Immunocompromised host

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CYCLOSPORIN; EVEROLIMUS; ITRACONAZOLE; METHYLPREDNISOLONE; MICONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POSACONAZOLE; VORICONAZOLE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; CANCER CHEMOTHERAPY; CHILD; DATA BASE; ENUCLEATION; FEMALE; FOLLOW UP; FUNGAL ENDOPHTHALMITIS; GRAFT VERSUS HOST REACTION; HEALTH SURVEY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCEDOSPORIUM APIOSPERMUM; SCHOOL CHILD; SURVIVAL RATE; SYSTEMIC THERAPY; TREATMENT OUTCOME; VITRECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FEMALE; FUNGI; HUMANS; IMMUNOCOMPROMISED HOST; INJECTIONS, INTRAOCULAR; LEUKEMIA; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VITRECTOMY; YOUNG ADULT;

ASPERGILLUS; FUNGI;

EID: 80054009004     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.02004.x     Document Type: Article

References (37)

1. Chamilos G, Luna M, Lewis RE et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-9.
2. Neofytos D, Horn D, Anaissie E et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48: 265-73.
3. Richardson M, Lass-Florl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 2008; 14(Suppl. 4): 5-24.
4. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000; 13: 662-85.
5. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43(Suppl. 1): S207-38.
6. Riddell IJ, McNeil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA. Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature. Medicine (Baltimore) 2002; 81: 311-20.
7. Weishaar PD, Flynn HW Jr, Murray TG et al. Endogenous Aspergillus endophthalmitis. Clinical features and treatment outcomes. Ophthalmology 1998; 105: 57-65.
8. Lamaris GA, Esmaeli B, Chamilos G et al. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 2008; 27: 343-7.
9. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
10. Aliyeva SE, Ullmann AJ, Kottler UB, Frising M, Schwenn O. Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report. Graefes Arch Clin Exp Ophthalmol 2004; 242: 887-91.
11. Bakri SJ, Sears JE, Procop GW, Shrestha R, Gordon SM. Excellent visual outcome following Aspergillus flavus endogenous endophthalmitis-farmer's lung disease. Int Ophthalmol 2009; 30: 99-101.
12. Bethell D, Hall G, Goodman TR, Klein N, Pollard AJ. Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy. J Pediatr Hematol Oncol 2004; 26: 304-7.
13. Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) 2003; 82: 97-105.
14. Hashemi SB, Shishegar M, Nikeghbalian S et al. Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report. Transplant Proc 2009; 41: 2933-5.
15. Kramer M, Kramer MR, Blau H, Bishara J, Axer-Siegel R, Weinberger D. Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis. Ophthalmology 2006; 113: 1184-6.
16. Logan S, Rajan M, Graham E, Johnson E, Klein J. A case of aspergillus endophthalmitis in an immuncompetent woman: intra-ocular penetration of oral voriconazole: a case report. Cases J 2010; 3: 31.
17. de O Machado D, Goncalves R, Fernandes EM, Campos WR, Orefice F, Curi AL. Bilateral Aspergillus endophthalmitis in a patient with chronic lymphocytic leukaemia. Br J Ophthalmol 2003; 87: 1429-30.
18. Perri P, Campa C, Incorvaia C et al. Endogenous Aspergillus versicolor endophthalmitis in an immuno-competent HIV-positive patient. Mycopathologia 2005; 160: 259-61.
19. Rana M, Fahad B, Abid Q. Embolic aspergillus endophthalmitis in an immunocompetent patient from aortic root aspergillus endocarditis. Mycoses 2008; 51: 352-3.
20. Reis LJ, Barton TD, Pochettino A et al. Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole. Clin Infect Dis 2005; 41: 752-3.
21. Schelenz S, Goldsmith DJ. Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients. J Infect 2003; 47: 336-43.
22. Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 2004; 137: 725-31.
23. Shen X, Xu G. Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm 2009; 17: 148-52.
24. Telander DG, Pambuccian SE, Olsen TW. Systemic Aspergillus presenting with visual symptoms. Retina 2004; 24: 166-8.
25. Willermain F, Bradstreet C, Kampouridis S et al. Different presentations of ophthalmic aspergillosis. Eur J Ophthalmol 2008; 18: 827-30.
26. Chen FK, Chen SD, Tay-Kearney ML. Intravitreal voriconazole for the treatment of endogenous endophthalmitis caused by Scedosporium apiospermum. Clin Experiment Ophthalmol 2007; 35: 382-5.
27. Figueroa MS, Fortun J, Clement A, De Arevalo BF. Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole. Retina 2004; 24: 319-20.
28. Jain A, Egbert P, McCulley TJ, Blumenkranz MS, Moshfeghi DM. Endogenous Scedosporium apiospermum endophthalmitis. Arch Ophthalmol 2007; 125: 1286-9.
29. Larocco A Jr, Barron JB. Endogenous Scedosporium apiospermum endophthalmitis. Retina 2005; 25: 1090-3.
30. Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Retina 2006; 26: 935-9.
31. Vagefi MR, Kim ET, Alvarado RG, Duncan JL, Howes EL, Crawford JB. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol 2005; 139: 370-3.
32. Rezai KA, Eliott D, Plous O, Vazquez JA, Abrams GW. Disseminated Fusarium infection presenting as bilateral endogenous endophthalmitis in a patient with acute myeloid leukemia. Arch Ophthalmol 2005; 123: 702-3.
33. Tiribelli M, Zaja F, Fili C et al. Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. Eur J Haematol 2002; 68: 314-7.
34. Gupta P, Sachdev N, Kaur J, Dey P, Gupta V, Gupta A. Endogenous mycotic endophthalmitis in an immunocompetent patient. Int Ophthalmol 2009; 29: 315-8.
35. Stock W. Eine metastatische Ophthalmie durch Schimmelpilze. Klin Monatsbl Augenheilk 1926; 76: 49-56.
36. Friedman AH, Chishti MI, Henkind P. Endogenous ocular aspergillosis. Ophthalmologica 1974; 168: 197-205.
37. Hariprasad SM, Mieler WF, Holz ER et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 2004; 122: 42-47.